2019
DOI: 10.1177/1533033819846638
|View full text |Cite|
|
Sign up to set email alerts
|

Downregulated Long Noncoding RNA PART1 Inhibits Proliferation and Promotes Apoptosis in Bladder Cancer

Abstract: Objective: In this study, we aimed to clarify the effects of long noncoding ribonucleic acid prostrate androgen-regulated transcript-1 on bladder cancer cell proliferation and apoptosis. Methods: Microarrays were implemented to investigate the long noncoding ribonucleic acid expression profiles in bladder cancer tissue (N = 9) and in noncancer bladder tissue (N = 5). Relative prostrate androgen-regulated transcript-1 expression levels in tissue samples or cell lines were detected by real-time quantitative reve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 23 publications
0
24
0
Order By: Relevance
“…28 The previous reports have suggested a controversial role of PART1 in cancers. For instance, Hu et al found that PART1 was overexpressed in bladder cancer specimens and silencing of PART1 led to cell proliferation inhibition and apoptosis in bladder cancer cells; 29 data mining of TCGA dataset revealed that higher expression of PART1 was associated with a higher risk of recurrence for patients with hepatocellular carcinoma; 30 in oral squamous cell carcinoma, however, patients with higher expression of PART1 exhibited longer overall survival compared with patients with lower expression of PART1. 31 Although one study indicated that higher expression of PART1 was associated with longer survival in patients with GBM, 32 the role and molecular mechanisms of PART1 in glioma are not known.…”
Section: Discussionmentioning
confidence: 99%
“…28 The previous reports have suggested a controversial role of PART1 in cancers. For instance, Hu et al found that PART1 was overexpressed in bladder cancer specimens and silencing of PART1 led to cell proliferation inhibition and apoptosis in bladder cancer cells; 29 data mining of TCGA dataset revealed that higher expression of PART1 was associated with a higher risk of recurrence for patients with hepatocellular carcinoma; 30 in oral squamous cell carcinoma, however, patients with higher expression of PART1 exhibited longer overall survival compared with patients with lower expression of PART1. 31 Although one study indicated that higher expression of PART1 was associated with longer survival in patients with GBM, 32 the role and molecular mechanisms of PART1 in glioma are not known.…”
Section: Discussionmentioning
confidence: 99%
“…LncRNAs, including exosomal lncRNAs, are involved in the pathology of various tumors, including BC . Zheng et al showed that exosomes derived from normal cells transfer lncRNA PTENP1 to BC cells, thus inhibiting the progression of BC both in vitro and in vivo, which suggested that exosomal PTENP1 was involved in normal‐cell‐to‐bladder‐cell communication during BC carcinogenesis .…”
Section: Discussionmentioning
confidence: 99%
“…[29][30][31] LncRNA PART1 has been reported to have controversial roles in cancers. In detail, PART1 acted as oncogenic factors in bladder cancer 32 and hepatocellular carcinoma, 33 while it acted as tumor suppressors in oral squamous cell carcinoma 22 and glioblastoma. 34,35 However, the biological effects and underlying mechanisms of PART1 on TSCC were unclear.…”
Section: Discussionmentioning
confidence: 99%